Effective control of blood glucose status and toxicity in streptozotocin-induced diabetic rats by orally administration of vanadate in an herbal decoction

Food and Chemical Toxicology

Volumn 46, Issue 9, 2008, Pages 2996-3002

  Zhang, L ^a   Zhang, Y ^b   Xia, Q ^b   Zhao, X M ^a   Cai, H X ^a   Li, D W ^a   Yang, X D ^b   Wang, K ^b   Xia, Z L ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Antioxidant; Diabetes; Vanadium

Indexed keywords

GLUCOSE; SALVIA MILTIORRHIZA EXTRACT; STREPTOZOCIN; VANADIC ACID;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DRUG POTENTIATION; GASTROINTESTINAL SYMPTOM; HYPOGLYCEMIA; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; EATING; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; MALE; ORGAN SIZE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SALVIA MILTIORRHIZA; VANADATES;

ANIMALIA; RATTUS; SALVIA MILTIORRHIZA;

EID: 50249097200     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.05.040     Document Type: Article

References (25)

1. Chen J., and Lin C.Q. Effect of Danshen on the prevention and treatment of liver cancer. Zhong Cao Yao 30 (1999) 226-228
2. Clark T.A., Heyliger C.E., Edel A.L., Goel D.P., and Pierce G.N. Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in streptozotocin-induced diabetic rats. Metabolism 53 9 (2004) 1145-1151
3. Clark T.A., Edel A.L., Heyliger C.E., and Pierce G.N. Effective control of glycemic status and toxicity in Zucker diabetic fatty rats with an orally administered vanadate compound. Can. J. Physiol. Pharmacol. 82 (2004) 888-894
4. Domingo J.L. Vanadium and diabetes: What about vanadium toxicity?. Mol. Cellular Biochem. 203 (2000) 185-187
5. Edel A.L., Kopilas M., Clark T.A., Aguilar F., Ganguly P.K., Heyliger C.E., and Pierce G.N. Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats. Metabolism 55 2 (2006) 263-270
6. Facchini D.M., Yuen V.G., Battell M.L., McNeill J.H., and Grynpas M.D. The effects of vanadium treatment on bone in diabetic and non-diabetic rats. J. Bone 38 3 (2006) 368-377
7. Forge A., and Schacht J. Aminoglycoside antibiotics. Audiol. Neuro-Otol. 5 (2000) 3-22 (Medline)
8. González E., Jawerbaum A., Sinner D., Pustovrh W.V., Capobianco E., Xaus C., Peralta C., and Roselló-Catafau J. Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway. Nitric. Oxide 6 (2002) 214-220 (CrossRef ISI Medline)
9. Huang Y.S., and Zhang J.T. Antioxidative effect of three water-soluble components isolated from Salvia Miltiorrhiza in vitro (Chinese). Yao Xue Xue Bao 27 (1992) 96-100 (Medline)
10. Luo J.Z., and Luo L.G. American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling Protein-2 in cultured ß Cells. eCAM 3 3 (2006) 365-372 10.1093/ecam/nel026
11. Mukherjee B., Patra B., Mahapatra P.J., Tiwari A., and Chatterjee M. Vanadium -- an element of atypical biological significance. Toxicol. Lett. 150 (2004) 135-143
12. Niu X.L., Ichimori K., Yang X., Hirota Y., Hoshiai K., Li M., and Nakazawa H. Tanshinone II-A inhibits low density lipoprotein oxidation in vitro. Free Radic. Res. 33 (2000) 305-312 Medline
13. Poucheret P., Verma S., Grynpas M.D., and MeNeill J.H. Vanadium and diabetes. Mol. Cellular Biochem. 188 (1998) 73-80
14. Rosenbloom A.L. Hyperglycemic crises and their complications in children. J. Pediatr. Endocrinol. Metab. 20 1 (2007) 5-18
15. Santoso T. Prevention of cardiovascular disease in diabetes mellitus: by stressing the CARDS study. Acta Med. Indones. 38 2 (2006) 97-102
16. Shechter Y., Goldwaser I., Mironchik M., Fridkin M.T., and Gefel D. Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes. Coordination Chem. Rev. 237 (2003) 3-11
17. Shi X., Jiang H., Mao Y., Ye J., and Saffiotti U. Vanadium(IV) mediated free radical generation and related 2′-deoxyguanosine hydroxylation and DNA damage. Toxicology 106 (1996) 27-38
18. Shukla R., Barve V., Padhye S., and Bhonde R. Reduction of oxidative stress induced vanadium toxicity by complexing with a flavonoid, quercetin: a pragmatic therapeutic approach for diabetes. Biometals 19 6 (2006) 685-693 Epub 2006 May 16
19. Soussi A., Croute F., Soleilhavoup J.P., Kammoun A., and El-Feki A. Impact of green tea on oxidative stress induced by ammonium metavanadate exposure in male rats. C R Biol. 329 10 (2006) 775-784 (Epub 2006 September 20)
20. Thompson K.H., and Orvig C. Vanadium in diabetes: 100 years from Phase 0 to Phase I. J. Inorg. Biochem. 100 12 (2006) 1925-1935
21. Wan E.C., Gordon T.P., and Jackson M.W. Autoantibody-mediated bladder dysfunction in type 1 diabetes. Scand J. Immunol. 65 1 (2007) 70-75
22. Wilsey J., Matheny M.K., and Scarpace P.J. Oral vanadium enhances the catabolic effects of central leptin in young adult rats endocrinology 147 1 (2006) 493-501 (CrossRef ISI Medline)
23. Yin D.P., Tao J., Lee D.D., Shen J.K., Hara M., Lopez J., Kuznetsov A., Philipson L.H., and Chong A.S. Recovery of Islet ß-Cell Function in Streptozotocin. Induced Diabetic Mice Diabetes 55 (2006) 3256-3263
24. Yokozawa T., Chung H.Y., Dong E., and Oura H. Confirmation that magnesium lithospermate B has a hydroxyl radical-scavenging action. Exp. Toxicol. Pathol. 47 (1995) 341-344 (Medline)
25. Zhang Y., Yang X., Wang K., and Crans D.C. The Permeability and Cytotoxicity of Insulin-mimetic Vanadium(III, IV, V)-Dipicolinate Complexes. JIB 100 (2006) 80-97